EUVIMEDEUVIMED entdecken
Crossref

Restoration of Lysosomal Hydrolase Activities by LRRK2 Inhibition in GBA1 ‐ and LRRK2 ‐Associated Parkinson's Disease Patient‐Derived Cells

T S Usenko iD, K S Basharova, A I Bezrukova, E V Grigor'eva, S V Pavlova, G V Baydakova, M A Nikolaev, I N Gaponenko, O V Khegay, I V Miliukhina, E Yu Zakharova, S N Pchelina

Journal of Neurochemistry · 2025

DOI: 10.1111/jnc.70214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurochemistry, 2025. Verfasst von T S Usenko und 11 weiteren Autor:innen. Beteiligte Einrichtung: Petersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Center "Kurchatov Institute", Gatchina, Russian Federation. Hauptthemen laut MEDLINE: Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Parkinson Disease, Glucosylceramidase, Lysosomes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mutations in the GBA1 gene, encoding the lysosomal enzyme glucocerebrosidase (GCase), and the LRRK2 gene, encoding leucine‐rich repeat kinase 2 (LRRK2) are the most common genetic risk factors for Parkinson's disease (PD). The potential use of LRRK2 inhibitors for treating not only LRRK2‐associated PD (LRRK2‐PD) but also GBA1‐associated PD (GBA1‐PD) is currently under discussion. In the present study, we aimed to evaluate whether LRRK2 inhibition affects lysosomal hydrolase enzymatic activities, autophagy, and alpha‐synuclein levels in various cell types derived from LRRK2‐PD and GBA1‐PD patients, including macrophages derived from peripheral blood mononuclear cells (PBMC‐derived macrophages), dopaminergic (DA) neurons derived from induced pluripotent stem cells (iPSC‐derived DA neurons), and SH‐SY5Y cells. We first characterized PBMC‐derived macrophages from patients with LRRK2‐PD. Confocal microscopy revealed reduced colocalization of GCase with the lysosomal marker LAMP2, indicating impaired lysosomal translocation of the enzyme. In parallel, we observed decreased activity of galactosylceramidase (GALC), increased levels of lysosphingolipids (HexSph, LysoGb3, LysoSM) as measured by LC–MS/MS, and decreased pro‐form of cathepsin D, as assessed by Western blot analysis, compared to controls. However, no significant differences in GCase activity and protein levels were observed in PBMC‐derived macrophages of LRRK2‐PD patients and controls. In subsequent experiments, we found that LRRK2 inhibition not only increased GCase activity in both PBMC‐derived macrophages and iPSC‐derived DA neurons but also augmented the activity of other lysosomal enzymes, including acid sphingomyelinase (ASMase), alpha‐galactosidase (GLA), and GALC. Notably, this enhancement was more pronounced in iPSC‐derived DA neurons compared to PBMC‐derived macrophages. Similar increases in lysosomal hydrolase activities (GCase, ASMase, GALC, and GLA) were also observed in the SH‐SY5Y neuroblastoma cell line after LRRK2 inhibition. Interestingly, LRRK2 inhibition was more effective in GBA1‐PD than in LRRK2‐PD. We demonstrated that LRRK2 inhibition enhances both the protein levels of GCase and its translocation to lysosomes. This study provides the first evidence that inhibition of LRRK2 activity may increase GCase level and its translocation to lysosomes, thereby ameliorating lysosomal function. Moreover, LRRK2 inhibition also enhances the activity of other lysosomal hydrolases. Our findings expand the understanding of the molecular mechanism of LRRK2 inhibitors, offering valuable insights for further development of PD treatments. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2Parkinson DiseaseGlucosylceramidaseLysosomesHydrolasesHumansMaleInduced Pluripotent Stem CellsFemaleAgedMiddle AgedMacrophagesDopaminergic NeuronsLeukocytes, Mononuclear

Stichwörter der Autor:innen

MLi‐2Parkinson diseasealpha‐synucleinglucocerebrosidaseleucine‐rich repeat kinase 2lysosomal hydrolases

Substanzen

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2GlucosylceramidaseLRRK2 protein, humanGBA protein, humanHydrolases

Autor:innen und Institutionen

  • Petersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Center "Kurchatov Institute", Gatchina, Russian Federation.
  • Pavlov First Saint-Petersburg State Medical University, Saint Petersburg, Russian Federation.
  • Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, Novosibirsk, Russian Federation.
  • Research Centre for Medical Genetics, Moscow, Russian Federation.
  • RM Gorbacheva Research Institute of Pediatric Oncology, Hematology and Transplantation, Pavlov University, Saint Petersburg, Russian Federation.
  • Institute of the Human Brain RAS, Saint Petersburg, Russian Federation.

ORCID-Profile: T S Usenko

Förderung

  • Russian Science Foundation

Zitieren

APA

Usenko, T. S., Basharova, K. S., Bezrukova, A. I., Grigor'eva, E. V., Pavlova, S. V., Baydakova, G. V., Nikolaev, M. A., Gaponenko, I. N., Khegay, O. V., Miliukhina, I. V., Zakharova, E. Y., & Pchelina, S. N. (2025). Restoration of Lysosomal Hydrolase Activities by LRRK2 Inhibition in GBA1 ‐ and LRRK2 ‐Associated Parkinson's Disease Patient‐Derived Cells. Journal of Neurochemistry. https://doi.org/10.1111/jnc.70214

Vancouver

Usenko TS, Basharova KS, Bezrukova AI, Grigor'eva EV, Pavlova SV, Baydakova GV, et al. Restoration of Lysosomal Hydrolase Activities by LRRK2 Inhibition in GBA1 ‐ and LRRK2 ‐Associated Parkinson's Disease Patient‐Derived Cells. Journal of Neurochemistry. 2025. doi:10.1111/jnc.70214

BibTeX
@article{Usenko2025,
  author = {Usenko, T S and Basharova, K S and Bezrukova, A I and Grigor'eva, E V and Pavlova, S V and Baydakova, G V and Nikolaev, M A and Gaponenko, I N and Khegay, O V and Miliukhina, I V and Zakharova, E Yu and Pchelina, S N},
  title = {Restoration of Lysosomal Hydrolase Activities by LRRK2 Inhibition in GBA1 ‐ and LRRK2 ‐Associated Parkinson's Disease Patient‐Derived Cells},
  journal = {Journal of Neurochemistry},
  year = {2025},
  doi = {10.1111/jnc.70214}
}
Kostenlos starten →